Pfizer cancer drug cuts breast cancer death risk

Pfizer cancer drug cuts breast cancer death risk

PHARMACEUTICAL giant Pfizer yesterday said its low-dose cancer drug abemaciclib effectively targeted and killed breast and ovarian cancer cells. The drug reduced the risk of dying from both of the most common types of…